ASTM F2475-20 PDF

Full title and description

ASTM F2475-20 — Standard Guide for Biocompatibility Evaluation of Medical Device Packaging Materials. This guide provides recommendations and a risk-based framework to determine appropriate biological and chemical testing for packaging materials and sterile barrier systems that have the potential to contact medical devices and, directly or indirectly, patients. It helps manufacturers decide when supplier history, screening data, or laboratory testing are required to demonstrate packaging biocompatibility and to protect device performance and patient safety.

Abstract

F2475-20 describes factors to consider when assessing the biocompatibility of primary packaging materials for medical devices. The guide emphasizes device/package interactions, the chemical nature of packaging materials, intended device use (including the extent and type of patient contact), and the possibility that existing experience with a material may obviate further testing. It references established biological evaluation frameworks (for example ISO 10993-1) and recommends a screening and test-selection approach consistent with a risk-management process.

General information

• Status: Active standard (current edition approved January 1, 2020).
• Publication date: 2020 (current edition approved Jan 1, 2020; published February 2020).
• Publisher: ASTM International.
• ICS / categories: 11.120.99 (other standards related to pharmaceutics); 55.020 (packaging and distribution of goods in general).
• Edition / version: F2475-20 (2020 edition).
• Number of pages: 3 pages.

Scope

This guide applies to primary packaging materials and sterile barrier systems for medical devices when those materials may contact the device and thereby have the potential to contact the patient directly or indirectly. It does not apply to secondary or tertiary packaging. The scope focuses on helping users select appropriate biocompatibility screening or testing—ranging from supplier-provided cytotoxicity data to more extensive chemical and biological testing—based on material chemistry, device type, intended use, and established history of safe use.

Key topics and requirements

• Risk-based selection of biocompatibility tests for packaging materials (consider chemical nature, device interactions, intended use).
• When supplier history and previous data are sufficient versus when laboratory testing is required.
• Screening tests (for example cytotoxicity) and selection of further tests consistent with ISO 10993‑1 principles.
• Consideration of sterile barrier systems and their role in protecting device biocompatibility and sterility.
• Guidance to integrate packaging biocompatibility evaluation into overall device risk management and regulatory submissions.
• References to related standards and guidance (ISO 10993-1, ANSI/AAMI/ISO 11607 series, ASTM terminology standards).

Typical use and users

Used by medical device manufacturers, packaging engineers, regulatory affairs and quality assurance professionals, sterilization specialists, contract testing laboratories, and notified bodies. Typical applications include pre-market evaluation of new packaging materials, supplier qualification, change-control assessments for packaging components, and preparation of evidence for regulatory submissions. The guide is practical for small and large device makers that must demonstrate that packaging will not negatively affect device safety or performance.

Related standards

Commonly referenced documents and related standards include ISO 10993-1 (Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process), ANSI/AAMI/ISO 11607-1 (Packaging for terminally sterilized medical devices — Requirements for materials, sterile barrier systems and packaging systems), ASTM terminology standards for packaging (for example F17), and regulatory guidance such as the FDA guidance on use of ISO 10993-1. F2475-20 is listed among consensus standards recognized by the FDA for sterility/biocompatibility matters.

Keywords

biocompatibility, medical device packaging, packaging materials, sterile barrier system, cytotoxicity screening, ISO 10993-1, risk assessment, packaging biocompatibility testing.

FAQ

Q: What is this standard?

A: ASTM F2475-20 is a guide that helps determine appropriate biocompatibility evaluation and testing for medical device primary packaging materials and sterile barrier systems.

Q: What does it cover?

A: It covers principles and a risk-based approach for selecting biological and chemical tests (or accepting supplier history) for packaging materials that may affect device safety or contact patients indirectly or directly. It excludes secondary and tertiary packaging.

Q: Who typically uses it?

A: Medical device manufacturers, packaging engineers, regulatory affairs and QA personnel, contract test labs, and certification/notification bodies use the guide when qualifying materials, assessing packaging changes, or preparing regulatory submissions.

Q: Is it current or superseded?

A: The 2020 edition (F2475-20) is the current edition (approved January 1, 2020). ASTM has active maintenance work items related to the document, and it is included in recognized-consensus lists (for example FDA recognition entries). Users should check ASTM or regulatory databases for any later revisions.

Q: Is it part of a series?

A: F2475 is a standalone guide focused on packaging biocompatibility but is intended to be used alongside a family of device and packaging standards and test methods (for example ISO 10993 series for biological evaluation and ANSI/AAMI/ISO 11607 series for sterile packaging).

Q: What are the key keywords?

A: Biocompatibility, packaging materials, sterile barrier system, cytotoxicity, ISO 10993, risk assessment, medical device packaging.